Showing 21 - 40 results of 69 for search '(( significantly ((we decrease) OR (mean decrease)) ) OR ( significance visits decreased ))~', query time: 0.75s Refine Results
  1. 21

    Data Sheet 1_Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica.docx by Laura Trives-Folguera (22449472)

    Published 2025
    “…We found a significant decrease in all laboratory and clinical parameters. …”
  2. 22

    Supplementary Material for: Status of inpatients with pediatric epilepsy in children’s hospitals in China (2016–2021) by Wang J. (3112815)

    Published 2024
    “…The root-mean-square-error between the Inter-Provincial Visits Indexes decreased from 1.70 to 0.90, decreasing significantly (R2=0.8306). …”
  3. 23

    Sex differences in the relationship of sleep-disordered breathing and asthma control among children with severe asthma by Sigfus Gunnlaugsson (10358988)

    Published 2021
    “…Multivariable linear regression models revealed a significant sex interaction with PSQ on asthma control (<i>p</i> = 0.003), such that for each 0.10 point increase in PSQ there was a 1.88 point decrease in ACT score for females but only 0.21 point decrease in ACT score for males. …”
  4. 24

    Supplementary Material for: Effectiveness of mepolizumab in patients with severe eosinophilic asthma with/without nasal polyposis: a real-life study by Bravo-Gutiérrez F.J. (17440509)

    Published 2023
    “…The median diary oral prednisone intake was 15 mg before treatment and 5 mg after treatment (mean 56% reduction). We have obtained a significant improvement in other variables: ED visits and hospitalizations, asthma control (ACT), quality of life (miniAQLQ), and lung function (FEV1). …”
  5. 25

    Supplementary Material for: Effect of frail phenotype on cardiorenal risk and healthcare utilization in older patients with chronic kidney disease by Sun C.-Y. (10070377)

    Published 2024
    “…Every one-point frailty elevated composite renal outcome risk by 28.0 % (HR: 1.28, 95% CI:1.03–1.59) and significantly increased secondary outcomes (hospitalization [HR: 1.24, 95% CI: 1.06–1.46], unexpected ER visit [HR: 1.20, [95% CI:1.03–1.39], and mortality [HR: 1.51, 95% CI: 1.06–2.16]) but not for MACE [HR: 1.43, 95% CI: 0.99–2.08]. …”
  6. 26

    Image1_The safe and effective use of supercritical CO2-processed bone allografts for cervical and lumbar interbody fusion: A retrospective study.png by Nicolas Aurouer (14577653)

    Published 2023
    “…Over 80% of patients reported good to excellent outcomes according to Odom's criteria, the perception of pain significantly decreased, and the mean NDI and ODI scores significantly improved at the last follow-up compared with before the operations. …”
  7. 27

    Image3_The safe and effective use of supercritical CO2-processed bone allografts for cervical and lumbar interbody fusion: A retrospective study.png by Nicolas Aurouer (14577653)

    Published 2023
    “…Over 80% of patients reported good to excellent outcomes according to Odom's criteria, the perception of pain significantly decreased, and the mean NDI and ODI scores significantly improved at the last follow-up compared with before the operations. …”
  8. 28

    Image2_The safe and effective use of supercritical CO2-processed bone allografts for cervical and lumbar interbody fusion: A retrospective study.png by Nicolas Aurouer (14577653)

    Published 2023
    “…Over 80% of patients reported good to excellent outcomes according to Odom's criteria, the perception of pain significantly decreased, and the mean NDI and ODI scores significantly improved at the last follow-up compared with before the operations. …”
  9. 29

    Supplementary file 1_An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study.... by Miguel Ángel Robles-Sánchez (21211703)

    Published 2025
    “…Lifestyle habits remained mostly unchanged, except for medication self-management and diet, whereas visits to nurses and other professionals in MS units significantly decreased. …”
  10. 30

    Table_1_Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment.DOCX by Jörg Wissel (5748323)

    Published 2020
    “…Patients in all groups showed a reduction in MAS scores from baseline over the consecutive injection visits (i.e., at end of each cycle). Although reductions in MAS scores descriptively favored the early treatment group, the difference compared to the late group did not reach statistical significance at the last study visit (ANCOVA: difference in adjusted means of 0.15, p = 0.546).…”
  11. 31

    Supplementary file 1_Emergency department overcrowding: first Swiss application of the Emergency Department Work Index and risk factors for overcrowding.pdf by Aline Herzog (22589720)

    Published 2025
    “…</p>Methods<p>In this retrospective analysis, we included consecutive ED visits at a tertiary care hospital between 1st December and 31st December 2016. …”
  12. 32

    Prospective evaluation of micropulse transscleral diode cyclophotocoagulation in refractory glaucoma: 1 year results by Alessandro Adad Jammal (7368773)

    Published 2019
    “…The mean number of medications significantly dropped to 2.00 ± 1.7 at the 12-month visit (p=0.044). …”
  13. 33

    Image_1_Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD.TIFF by Susanna Asseyer (5705573)

    Published 2024
    “…Our case series including two AQP4-IgG + NMOSD patients revealed SC GM% increased by roughly 2% with either a myelitis or optic neuritis attack between visits. Meanwhile, GM% decreased by 1–2% in two MOGAD patients with a myelitis attack between MRI visits.…”
  14. 34

    Table_1_Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD.pdf by Susanna Asseyer (5705573)

    Published 2024
    “…Our case series including two AQP4-IgG + NMOSD patients revealed SC GM% increased by roughly 2% with either a myelitis or optic neuritis attack between visits. Meanwhile, GM% decreased by 1–2% in two MOGAD patients with a myelitis attack between MRI visits.…”
  15. 35

    Data Sheet 1_Campylobacter colonization and undernutrition in infants in rural eastern Ethiopia — a longitudinal community-based birth cohort study.docx by Dehao Chen (4966207)

    Published 2025
    “…</p>Results<p>The Campylobacter load in infant stools increased with age. The mean length-for-age Z-score (LAZ) decreased from −0.45 at 3–4 months of age to −2.06 at 13 months, while the prevalence of stunting increased from 3 to 51%. …”
  16. 36

    DataSheet1_A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in China.docx by Xu Han (141301)

    Published 2024
    “…Except for the Recombinant COVID-19 Vaccine (Sf9 Cells) vaccine having the highest neutralizing antibody GMT at the second visit (although there was no statistically significant difference in geometric mean titers between V1 and V2), the rest of the vaccines had the highest levels of binding antibodies and neutralizing antibodies at V1. …”
  17. 37

    Supplementary Material for: Evaluation of the First-dose Anti-VEGF Anatomical Response in Polypoidal Choroidal Vasculopathy Patients: Correlation with the Third-dose Response and R... by Wang Y. (2884271)

    Published 2023
    “…CMT in the good first-dose response group was significantly decreased from baseline at all first-year follow-up visits in both groups (p<0.001), and mean BCVA was improved in the good vs. poor first-dose anatomical response group (5.4 vs. 1.6 ETDRS letters in pachy-PCV, 10.6 vs. 7.4 letters in non-pachy-PCV) after the third injection. …”
  18. 38

    Table2_Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study.docx by Wei Cheng (52808)

    Published 2021
    “…Baseline data were collected at the first visit. Minimum clinically important difference (MCID) was defined as attaining a COPD assessment test (CAT) decrease ≥2. …”
  19. 39

    Table1_Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study.docx by Wei Cheng (52808)

    Published 2021
    “…Baseline data were collected at the first visit. Minimum clinically important difference (MCID) was defined as attaining a COPD assessment test (CAT) decrease ≥2. …”
  20. 40

    Table3_Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study.docx by Wei Cheng (52808)

    Published 2021
    “…Baseline data were collected at the first visit. Minimum clinically important difference (MCID) was defined as attaining a COPD assessment test (CAT) decrease ≥2. …”